Updates

Benchmark

December 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

The shares took off after Benchmark announced a whopping placing of 82.4m shares at 85p to raise £70m to fund two transformational acquisitions that move the business into acquaculture breeding and genetics.It is buying SalmoBreed, a salmon genetics company based in the US, for an initial £19.5m with a further £2.9m based on future performance. The second proposed deal is to buy 81.8% of Stofnfiskur, also a salmon breeding company in Iceland for an upfront consideration of £20.7m plus an earn-out of £8.3m. Marrying the two businesses together will result in a new business division, Benchmark Genetics, which will be the world's no.2 salmon egg producer. SalmoBreed, across the past severa ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

First Derivatives

Majestic Wine - Sterling strengthening helps

Benchmark - Woodford overhang clears (July 2019)

Benchmark (July 2018)

Benchmark - Product launches set for big uptick (December 2017)

Benchmark (November 2017)

Benchmark - Outer year forecasts will rise once capacity comes on stream (September 2016)

Benchmark (August 2016)

Benchmark - Down but certainly not out (March 2016)

Benchmark (January 2016)

Benchmark - Reverse takeover talks (November 2015)

Benchmark - Buys tilapia breeding business for £11m (September 2015)

Benchmark (July 2015)

Benchmark (May 2015)

Benchmark - Acquires veterinary training business (March 2015)

Benchmark (February 2015)

Benchmarck - Exciting new vaccine for cats (September 2014)

Benchmark - Not long for the new products to emerge (July 2014)

Benchmark - Top dog in aquafarming sector (May 2014)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X